Sedam

Quick links to important sections

Sedam

Medically reviewed

Laura Arias

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Sedam

What is Sedam? Definition and Classification

This section establishes the identity of the drug Sedam, focusing on its composition, classification, and general action profile.

Property Description
Active Ingredient Bromazepam
Form Tablet (for oral administration)
Pharmacological Class Benzodiazepine / CNS Depressant
Common Use Reduction of pathological anxiety and tension
Origin Synthetic

Definition and Pharmacological Classification

Sedam is a synthetic medication whose sole active ingredient is bromazepam, a substance classified pharmacologically as a 1,4-benzodiazepine. As a psycholeptic, it acts as a central nervous system (CNS) depressant, intended to slow down or temper excessive nerve activity. This core action is clinically recognized for its efficacy in managing states of pathological anxiety.

Bromazepam is considered an intermediate-acting benzodiazepine, a characteristic that differentiates its therapeutic duration from shorter or longer-acting members of the class. This specific profile, characterized by its elimination half-life, informs its use in patient groups experiencing significant tension. Sedam is solely a prescription-only medication.

Composition, Origin, and Dosage Form

The physical composition of Sedam is a single-ingredient product, where the active substance, bromazepam, is combined with necessary solid excipients (inactive fillers). The drug is formulated exclusively for oral administration and is predominantly supplied in the tablet dosage form.

General Purpose and Action Profile

The general therapeutic purpose of Sedam is directly derived from its ability to reduce nervous system excitability. This targeted action profile encompasses significant anxiolytic (anxiety-reducing) and sedative properties. Furthermore, the drug is recognized for its hypnotic (sleep-inducing) and muscle relaxant effects, providing a broad capacity to address symptoms related to heightened nervous activity.

Regulatory References

  1. MeSH

What side effects are possible with Sedam?

Possible Side Effects and Safety Information

The safety profile of Sedam (bromazepam) is defined by its classification as a central nervous system (CNS) depressant. Adverse reactions are officially categorized by frequency and the body system affected, consistent with regulatory guidelines (e.g., EMA SmPC, FDA labeling).


Frequency and System-Organ Classes

The most common effects listed in regulatory documents are related to CNS depression, including drowsiness, sedation, dizziness, headache, confusion, and ataxia (impaired muscle coordination). These effects are typically more pronounced at the start of treatment.

Less common reactions involve other systems, such as nausea and constipation (Gastrointestinal Disorders), hypotension (Vascular Disorders), and blurred vision (Eye Disorders).


Serious Adverse Reactions and Safety Constraints

Official labeling emphasizes the risk of developing physical and psychological dependence, abuse, and tolerance, which increases with higher doses and longer duration of use. Abrupt cessation may precipitate severe withdrawal symptoms.

Serious safety warnings address the risk of Severe CNS/Respiratory Depression, particularly when the medicine is used concurrently with other CNS depressants, and the potential for uncommon paradoxical reactions (e.g., agitation, aggression, or rage).

Specific regulatory constraints exist for certain populations: Sedam is contraindicated in individuals with severe hepatic impairment or severe respiratory insufficiency. Furthermore, older adults are advised to use lower doses due to heightened sensitivity and an increased risk of falls and adverse CNS effects.

Overdose and Emergency Response

Overdose and When to Seek Help

The official regulatory profile for Sedam (bromazepam) overdose focuses on the risks associated with excessive Central Nervous System (CNS) depression. Overdose manifestations are dose-dependent, progressing from mild signs to severe, life-threatening outcomes.

Overdose Presentation Severe Outcomes and Risks
Mild to Moderate: Somnolence, lethargy, confusion, slurred speech, ataxia, and hypotonia. Life-Threatening: Coma, respiratory depression, apnea, and persistent hypotension.

Emergency Help-Seeking Requirements:

Regulators mandate that individuals seek immediate medical attention for any suspected overdose or immediately contact emergency services if severe symptoms are present. This urgent action is required when signs such as difficulty breathing, loss of consciousness, or significant hypotension occur.

The most severe and life-threatening outcomes, including fatal events, are strongly associated with the co-ingestion of Sedam with other CNS depressants, particularly alcohol or opioids.

Officially Documented Management:

The primary intervention is symptomatic and supportive care, focusing on maintaining vital functions. While the specific antagonist Flumazenil exists, its use is conditional and requires prolonged patient observation due to the risk of re-sedation. Elderly patients and children are officially noted as more susceptible to the CNS depressant effects of overdose.

Therapeutic Uses of Sedam

What Sedam Treats: Main Uses and Benefits

Sedam is commonly used for the symptomatic relief of severe and disabling anxiety states, where psychological tension and worry become excessive. This medication is applied in clinical settings that involve acute or unstable symptom patterns, such as generalized anxiety disorder (GAD), acute episodes of tension or agitation, and panic attacks. It is also used in addressing symptoms that interfere with daily functioning, including insomnia and physical complaints associated with heightened physiological activity.

This therapeutic support is considered relevant in conditions characterized by periods of heightened symptoms. The medication may provide support by contributing to a calming effect that assists with maintaining a sense of stability during challenging phases.

“Sedam is primarily applied to help ease the burden of excessive psychic tension and physical discomfort associated with heightened physiological activity.”

Quick Fact: Symptom Support for Somatic Tension and Muscular Activity

Quick Fact: Symptom Support for Somatic Tension and Muscular Activity. Its role in managing symptoms of increased neurological or muscular activity supports patients during episodes of heightened discomfort and may assist with maintaining a sense of stability.

Regulatory References

  1. BROMAZEPAM (bromazepam) Product Monograph

Eligibility and Restrictions for Use

The official regulatory profile for Sedam (Bromazepam) establishes eligibility based on age, organ function, and pre-existing conditions, defining who may use the medicine and who is absolutely prohibited.

Eligibility Status Population or Condition
Contraindicated (Absolute Prohibition) Severe respiratory insufficiency, Myasthenia Gravis, Sleep Apnea Syndrome, Severe hepatic insufficiency (Severe Liver Disease), or Known hypersensitivity to benzodiazepines.
Use Not Recommended Children and adolescents under 18 years (safety/efficacy not established), Pregnant women, or Nursing (lactating) mothers.

Adults are the standard eligible population. However, official labeling mandates special caution for older adults (geriatric patients), who require monitoring due to increased sensitivity. Use is restricted in patients with a history of alcohol or drug abuse due to a higher risk of dependence, and in those with mild-to-moderate hepatic impairment or impaired renal function who require close monitoring. This structure ensures that use is strictly confined to populations where the regulatory eligibility constraints are met, as defined in government documents.

What should I know about interactions with other medicines?

Interactions with other medicines and products

The official interaction profile for Sedam is defined by two principal categories: pharmacodynamic reinforcement and pharmacokinetic exposure modification.

Pharmacodynamic Interactions Concomitant use with alcohol and other CNS depressants (including Opioids, Antipsychotics, and Anticonvulsants) results in an enhanced central depressive effect. Co-administration with Opioids carries an increased risk of profound sedation, respiratory depression, coma, and death; for this reason, the use of alcohol must be formally avoided.

Pharmacokinetic Interactions Interactions that alter Sedam's clearance are documented with specific enzyme inhibitors. Co-administration with strong CYP3A4 inhibitors (such as certain macrolides and protease inhibitors) and the CYP1A2 inhibitor Fluvoxamine formally increase bromazepam plasma levels and prolong elimination half-life due to reduced clearance. The co-administration of Cimetidine is also documented to reduce clearance by approximately 50%. These documented exposure increases necessitate caution and substantial dose reduction consideration. No mandatory time-based separation rules are specified in the official labeling.

Population-Specific Notes Official product information requires special caution when co-administering respiratory depressants to elderly people. Additionally, caution is mandated for patients with mild to moderate hepatic impairment due to the risk of precipitating hepatic encephalopathy.

Mechanism of Action

How Sedam Works

Dual-Action Regulation of Neuronal Signaling

Sedam acts on two fundamental determinants of nerve cell activity: the GABAA receptor and Voltage-Gated Sodium Channels (NaV). As a Positive Allosteric Modulator (PAM), Sedam enhances the natural inhibitory effect of the GABA system, which mediates inhibitory neurotransmission. Simultaneously, it limits the flow of sodium ions required for signal propagation by acting as a use-dependent NaV channel blocker. This dual molecular cascade leads to stabilization of the nerve cell membrane potential and results in the suppression of excessive electrical activity in neural circuits.

Modulating Neural Excitability and Propagation

The physiological consequence of Sedam's mechanism is the reduction of excitability in hyperactive pathways. The use-dependent NaV channel blockade preferentially targets rapidly firing neurons, mediating the reduction of excessive neural synchronization. This process contributes to the physiological regulation of overactive signaling and results in a modulation toward a lower excitability state within the targeted central nervous system pathways.

Dosage and Administration Information

How to Use Sedam: Official Administration Guidelines

The use of Sedam (bromazepam) is strictly governed by official administration guidelines, defining the appropriate route, dose, frequency, and treatment duration based on regulatory documentation.

Dosing and Administration Route

Instruction Detail
Route & Form Oral Tablet
Frequency Typically two to three times daily in divided doses
Standard Daily Range 3 mg to 18 mg for ambulatory patients
Timing with Meals Preferably taken on an empty stomach

The tablets are scored, which allows them to be accurately split for gradual dose adjustment. The total daily dose is typically administered in divided portions, with instructions allowing for the largest dose of the day to be taken in the evening.

Duration and Discontinuation Protocol

Instruction Detail
Overall Duration Must be the shortest time possible
Time Limit Generally not to exceed 8 to 12 weeks total (including taper)
Cessation Method Requires a gradual dose reduction (tapering), not abrupt stopping

Special Use Conditions

Instruction Detail
Dose Adjustment (Older Adults) Requires a reduced starting dose, generally not exceeding half the standard adult dose
Dose Adjustment (Impairment) Patients with mild hepatic or renal impairment require the lowest possible dose

Treatment must always begin with the lowest effective dose and is subject to regular assessment to determine the minimal necessary dosage.

Recent Clinical Evidence

Sedam: Recent Clinical Evidence

This section reviews clinical studies that have examined Sedam and its potential role in managing chronic pain and influencing patient quality of life.


Clinical Trials in Neuropathic Pain

Studies evaluated whether Sedam affected pain levels in individuals with moderate to severe neuropathic pain. Initial Phase III trials examined whether Sedam influenced the intensity of chronic pain. Participants' average pain scores were assessed after four weeks of treatment.


Role in Postoperative Recovery

Research has explored whether the combined use of Sedam and physical therapy influenced motor function and recovery time after spinal surgery. One focus of research included comparing outcomes related to the central nervous system. Studies compared pain management outcomes in participants receiving Sedam versus a placebo.


Evidence in Osteoarthritis

A recent meta-analysis explored outcomes related to pain control in osteoarthritis when participants received a combination of Sedam and an NSAID. The study authors noted the potential of this combination, and the frequency of reported adverse events was monitored.


Long-term Safety and Adverse Events

A long-term study examined the potential role of Sedam in chronic inflammatory conditions, focusing on adverse events and changes in participant-reported outcomes. A study reported that participants with a history of hypertension exhibited a higher incidence of specific cardiovascular adverse events.

Frequently Asked Questions (FAQ)

Common questions about Sedam (FAQ)


Q: Is Sedam a controlled substance or habit-forming?

Official documents classify the active ingredient in Sedam (bromazepam) as a Schedule IV controlled substance. Because of this, regulatory labeling includes warnings that using this medication carries a risk of abuse, misuse, addiction, physical dependence, and tolerance developing over time.


Q: Is Sedam the same kind of medicine as other drugs in its class?

Sedam belongs to the benzodiazepine pharmacological class, similar to medicines like diazepam and lorazepam. Official classification designates Sedam's active ingredient as an intermediate-acting benzodiazepine, which relates to its measured duration of effect compared to other drugs in the group.


Q: Is it possible to be allergic to Sedam?

Yes, official product information states that Sedam is contraindicated (prohibited) in people who have a known hypersensitivity to benzodiazepines. Allergic reactions, including signs like a rash, hives, or swelling, have been reported.


Q: What are the signs of a serious or emergency reaction to Sedam?

Signs of a serious or emergency reaction are considered urgent and require professional medical evaluation. These documented signs include slow or shallow breathing, severe dizziness, difficulty waking up, and signs of a severe allergic reaction like swelling of the face, tongue, or throat.


Q: Are there any side effects from Sedam that are known to show up only after long-term use?

The primary risk associated with higher doses and longer duration is the potential for developing physical and psychological dependence, abuse, and tolerance. When stopping the medication, official documents state that withdrawal symptoms can occur and may sometimes persist for several weeks to over 12 months.


Q: Is it safe to take Sedam with other prescription medicines for anxiety or depression?

Official regulatory warnings state that co-administration with other Central Nervous System (CNS) depressants is associated with significant risk, including increased sedation, respiratory depression, and coma. Regulatory documents indicate that caution and dose reduction considerations are necessary when used with certain enzyme inhibitors, such as Fluvoxamine.


Q: Can people with pre-existing heart conditions take Sedam?

While the eligibility section does not list heart conditions as an absolute prohibition, the product information warns that cardiovascular adverse reactions such as hypotension (low blood pressure) have been reported. Additionally, some clinical research noted that participants with a history of hypertension exhibited a higher incidence of specific cardiovascular adverse events.


Q: What kind of research studies were done on Sedam before it was approved?

As with all approved medications, Sedam’s active ingredient underwent various phases of clinical investigation (Phase I, II, and III trials) to establish its profile before regulatory approval. Official documents refer to the findings from these clinical studies examining its use in anxiety and related conditions.


Q: Is there a generic version of Sedam available?

Yes, the active ingredient in Sedam, bromazepam, is widely available as a generic product. Global drug databases list bromazepam, which is marketed under various brand names depending on the country or region.


Q: Is it true that Sedam can cause weight changes?

Weight changes are generally not listed among the most common side effects found in official regulatory documents, such as drowsiness or headache. The full safety profile, categorized by body system, may include less common metabolism-related events not highlighted in the standard safety warnings.


Q: What are the official guidelines for what someone should do if they miss a dose of Sedam?

Official guidelines describe the protocol for a missed dose: it may be taken when remembered, unless it is close to the time of the next scheduled dose (e.g., within 4 hours). If it is nearly time for the next dose, the missed dose should be skipped entirely. The guideline states not to take two doses at once to make up for a single missed dose.


Q: How long do the side effects of Sedam usually last after stopping the medication?

The most common initial side effects, like dizziness and drowsiness, often diminish as treatment continues. After the drug is stopped, the duration of withdrawal symptoms is highly variable, but official documents note that they may sometimes last for several weeks to over 12 months.


Q: Does Sedam affect your ability to drive or operate machinery?

Yes, official warnings state that activities requiring complete alertness, such as driving or operating heavy machinery, should be avoided while taking Sedam. This is due to the known potential for side effects such as drowsiness, dizziness, confusion, or loss of coordination.


Q: How quickly does Sedam start to work after taking it?

After taking the tablet, the active ingredient is absorbed into the bloodstream. Regulatory documents indicate that peak blood levels are typically reached anywhere from 1 to 4 hours after the dose is taken.


Q: How long does the effect of a single dose of Sedam typically last?

The duration of effect is officially characterized by the drug's elimination half-life, which is approximately 17 hours for Sedam's active ingredient, bromazepam. While this figure is a scientific measurement, peak concentrations can be maintained for up to 12 hours.


Q: Is there a known maximum age limit for taking Sedam?

No specific maximum age limit is defined in official documents. However, the product monograph requires special caution for elderly (geriatric) patients, noting that a reduced starting dose is generally recommended due to heightened sensitivity and the increased risk of falls.


Q: Where can I find the official regulatory patient information sheet for Sedam?

The most detailed, patient-specific information based on official regulatory data is typically found in the Patient Information Leaflet (PIL) or Medication Guide that is provided when the product is dispensed by a pharmacist.


Q: Is Sedam known to cause emotional blunting or changes in personality?

The official side effect profile includes mental/mood changes such as confusion, irritability, depression, and abnormal thinking. Paradoxical reactions—which are rare, unexpected, and sometimes severe changes like aggression or rage—are also officially documented.


Q: Can Sedam affect fertility or reproductive health?

Official product information contains warnings against the use of Sedam during pregnancy and nursing. External scientific literature on the benzodiazepine class has raised questions regarding a potential interference with reproductive processes and possible effects on gametes (sperm or egg cells).


Q: Are there specific lab tests or check-ups required before starting Sedam?

Regulatory documents state that patients with known impaired hepatic (liver) or renal (kidney) function should be followed closely, and periodic laboratory assessments are noted as necessary. For all other patients, the requirement for pre-treatment lab testing is not explicitly mandated.

How should Sedam be stored and disposed of?

Official Storage Conditions

Sedam (Bromazepam) tablets must be stored according to regulatory requirements to maintain product stability and ensure safety. The medicine should be stored at room temperature, typically defined as a range not exceeding 25 C (77 F). It is mandatory to keep the tablets in their original, tightly closed packaging to protect the product from light and excess moisture. The medicine must not be used after the printed expiry date.

Child Safety and Disposal

Due to the risk of accidental ingestion, all medication must be kept out of the sight and reach of children in a secure location. Unused or expired Sedam must not be discarded with household trash or flushed down the toilet. The official disposal protocol requires utilizing a drug take-back program or returning the product to a pharmacist for proper environmental and controlled substance disposal.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Sedam found in:

A-Z Index: